Pfizer's Lyme disease vaccine shows 70% efficacy despite trial shortfall Mar 23, 2026 · Cris Tolomia Pfizer wants to fill a 20-year void in human Lyme disease vaccines, but must win over regulators under a vaccine-skeptical administration Read more »